Advanced search
Publication Cover
Platelets Volume 27, 2016 - Issue 5
Submit an article Journal homepage
360
Views
38
CrossRef citations to date
0
Altmetric
Original Article

Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: Anticoagulant removal and reduction in activator concentration

Eduardo AnituaBTI-Biotechnology Institute, Vitoria, Spain;Eduardo Anitua Foundation for Biomedical Research, Vitoria, SpainView further author information
,
Roberto PradoBTI-Biotechnology Institute, Vitoria, SpainView further author information
,
María TroyaBTI-Biotechnology Institute, Vitoria, SpainView further author information
,
Mar ZalduendoBTI-Biotechnology Institute, Vitoria, SpainView further author information
,
María de la FuenteBTI-Biotechnology Institute, Vitoria, SpainView further author information
,
Ander PinoBTI-Biotechnology Institute, Vitoria, SpainView further author information
,
Francisco MuruzabalBTI-Biotechnology Institute, Vitoria, SpainView further author information
&
Gorka OriveBTI-Biotechnology Institute, Vitoria, Spain;Eduardo Anitua Foundation for Biomedical Research, Vitoria, SpainCorrespondence[email protected]
View further author information
 show all
Pages 459-466 | Received 26 Oct 2015, Accepted 18 Dec 2015, Published online: 04 Mar 2016

References

  • Anitua E, Sanchez M, Orive G, Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007;28:4551–4560.
  • Sanchez M, Delgado D, Sanchez P, Fiz N, Azofra J, Orive G, Anitua E, Padilla S. Platelet rich plasma and knee surgery. Biomed Res Int 2014;2014: 890630.
  • Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release 2012;157:29–38.
  • Anitua E, Prado R, Orive G. Endogenous morphogens and fibrin bioscaffolds for stem cell therapeutics. Trends Biotechnol 2013;31:364–374.
  • Anitua E, Tejero R, Alkhraisat MH, Orive G. Platelet-rich plasma to improve the bio-functionality of biomaterials. BioDrugs 2013;27:97–111.
  • Anitua E, Prado R, Sánchez M, Orive G. Platelet-rich plasma: Preparation and formulation. Oper Tech Orthop 2012;22:25–32.
  • Manual on borderline and classification in the Community Regulatory framework for medical devices. Version 1.17., 2015. Available at http://ec.europa.eu/DocsRoom/documents/12867
  • World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2013;310:2191–2194.
  • Farrugia A, Hughes C, Douglas S, Neal M, James J. Microtitre plate measurement of platelet response to hypotonic stress. J Clin Pathol 1989;42:1298–1301.
  • Goodall AH, Appleby J. Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation. Methods Mol Biol 2004;272:225–253.
  • Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178–195.
  • Wang S, Gao Z, Chen X, Lian X, Zhu H, Zheng J, Sun L. The anticoagulant ability of ferulic acid and its applications for improving the blood compatibility of silk fibroin. Biomed Mater 2008;3:044106.
  • Lian L, Suzuki A, Hayes V, Saha S, Han X, Xu T, Yates JR III, Poncz M, Kashina A, Abrams CS. Loss of ATE1-mediated arginylation leads to impaired platelet myosin phosphorylation, clot retraction, and in vivo thrombosis formation. Haematologica 2014;99:554–560.
  • Bjoraker DG, Ketcham TR. 3.8% sodium citrate (1:9) is an inadequate anticoagulant for rabbit blood with high calcium. Thromb Res 1981;24:505–508.
  • Anitua E, Sanchez M, Aguirre JJ, Prado R, Padilla S, Orive G. Efficacy and safety of plasma rich in growth factors intra-articular infiltrations in the treatment of knee osteoarthritis. Arthroscopy 2014;30:1006–1017.
  • Ganong WF, Barrett KE. General principles & energy production in medical physiology. In: Ganong WF, editor. Review of medical physiology. New York: McGraw-Hill Medical; 2005. p. 1–30.
  • Dumont LJ, Aubuchon JP, Gulliksson H, Slichter SJ, Elfath MD, Holme S, Murphy JR, Rose LE, Popovsky MA, Murphy S. In vitro pH effects on in vivo recovery and survival of platelets: An analysis by the BEST Collaborative. Transfusion 2006;46:1300–1305.
  • Summerer MH, Genco PV, Katz AJ. The response of human platelets to hypotonic stress: Direct measurement of volume change. Ann Clin Lab Sci 1978;8:447–452.
  • Kim BK, Baldini MG. The platelet response to hypotonic shock. Its value as an indicator of platelet viability after storage. Transfusion 1974;14:130–138.
  • Magalon J, Bausset O, Serratrice N, Giraudo L, Aboudou H, Veran J, Magalon G, Dignat-Georges F, Sabatier F. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthrosc J Arthrosc Relat Surg 2014;30:629–638.
  • Anitua E, Troya M, Zalduendo MM, Orive G. The effect of different drugs on the preparation and biological outcomes of plasma rich in growth factors. Ann Anat 2014;196:423–429.
  • Zhou L, Schmaier AH. Platelet aggregation testing in platelet-rich plasma: Description of procedures with the aim to develop standards in the field. Am J Clin Pathol 2005;123:172–183.
  • Anitua E, Sanchez M, Merayo-Lloves J, De La Fuente M, Muruzabal F, Orive G. Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation. Invest Ophthalmol Vis Sci 2011;52:6066–6073.
  • Anitua E, Pelacho B, Prado R, Aguirre JJ, Sanchez M, Padilla S, Aranguren XL, Abizanda G, Collantes M, Hernandez M, et al. Infiltration of plasma rich in growth factors enhances in vivo angiogenesis and improves reperfusion and tissue remodeling after severe hind limb ischemia. J Controlled Release 2015;202:31–39.
  • Hamm LL. Renal handling of citrate. Kidney Int 1990;38:728–735.
  • Anitua E, Prado R, Orive G. Closing regulatory gaps: New ground rules for platelet-rich plasma. Trends Biotechnol 2015;33:492–495.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.